Neoadjuvant Pembrolizumab for Lung Cancer | NEJM
Автор: NEJM Group
Загружено: 2023-08-10
Просмотров: 4416
Adjuvant pembrolizumab can improve disease-free survival among patients
with early-stage non–small-cell lung cancer. The effects of neoadjuvant
pembrolizumab in these patients are unclear.
New research findings are
summarized in this short video.
To see the full article, follow this link: https://nej.md/3WK7LMs
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: